Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in ...

The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal ...
The Caledonian-Record

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment ...

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

Management is scheduled to present on Thursday, December 11 at 10:45 am ET. Interested parties may access a live and archived webcast of the presentation on the “Event Calendar” page of the “Investors ...
TipRanks on MSN

Iridex’s MicroPulse technology shows efficacy in glaucoma management study

Iridex (IRIX) announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that ...
Ophthalmology Times

Study maps thermal dynamics of glaucoma laser treatments

The study evaluated thermal dynamics associated with CW-TSCPC and TLT using MicroPulse technology, such as temperature peak, ...
TipRanks on MSN

Iridex announces new study in TVST on glaucoma treatments

Iridex (IRIX) announced a newly published study in Translational Vision Science & Technology, TVST, examining the thermal dynamics of transscleral ...